Efficacy and safety of gemcitabine, oxaliplatin and paclitaxel (GOP) in cisplatin-refractory germ cell tumors in routine care: Registry data from an outcomes research project.

Christoph Seidel,Anja Lorch,Annette Dieing,Marcus Hentrich,Mareike Hornig,Viktor Grünwald,Richard Cathomas,Johannes Meiler,Maike de Wit,Carsten Bokemeyer,Karin Oechsle

Efficacy and safety of gemcitabine, oxaliplatin and paclitaxel (GOP) in cisplatin-refractory germ cell tumors in routine care: Registry data from an outcomes research project.

2015

Christoph Seidel
Anja Lorch
Annette Dieing
Marcus Hentrich
Mareike Hornig
Viktor Grünwald
Richard Cathomas
Johannes Meiler
Maike de Wit
Carsten Bokemeyer
Karin Oechsle

e15570 Background: Chemotherapy (CTX) with gemcitabine, oxaliplatin and paclitaxel (GOP) has demonstrated efficacy in multiply relapsed and/or cisplatin-refractory germ cell tumor (TGCT) patients (...

Keywords:

Refractory
Gemcitabine/oxaliplatin
Germ cell tumors
Outcomes research
Oncology
Pathology
Paclitaxel
Cisplatin
Internal medicine
Medicine
Oxaliplatin
routine care
Gemcitabine
Germ cell
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations